[Countermeasures against patient misidentification in laboratory study--chairmen's introductory remarks]

Naoto Shimetani1, Hiroshi Yoshida

  • 1Department of Laboratory Medicine, International University of Health and Welfare Atami Hospital, Atami 413-0012, Japan. shime@iuhw.ac.jp

Rinsho Byori. the Japanese Journal of Clinical Pathology
|November 14, 2013
PubMed

Insights

Patient misidentification in healthcare settings can lead to serious medical errors. This symposium reviewed strategies, including electronic verification systems and human factor approaches, to improve medical safety and prevent specimen misidentification.

Area of Science:

  • Medical Safety
  • Laboratory Medicine
  • Healthcare Risk Management

Context:

  • Patient misidentification is a significant risk in clinical practice, leading to critical medical errors.
  • The Japanese Society of Laboratory Medicine established a Medical Safety Committee in response to the "National Joint Action of Risk Management" initiative.
  • Annual symposia are held to raise awareness and discuss advancements in medical safety.

Purpose:

  • To review countermeasures against specimen misidentification in pathological examinations.
  • To explore the use of electronic patient verification systems in preventing blood sample misidentification.
  • To discuss human factor approaches, including process management and understanding human limitations, in enhancing medical safety.

Summary:

  • The symposium covered strategies for preventing specimen misidentification, focusing on pathological exams.
  • Discussions included the efficacy of electronic patient verification systems versus traditional methods in hospitals.
  • A key topic was the integration of human factor considerations into medical safety protocols to mitigate errors.

Impact:

  • Highlights the critical need for robust systems to prevent patient misidentification and associated medical errors.
  • Emphasizes the importance of both technological solutions (electronic verification) and human-centric approaches in healthcare safety.
  • Provides insights into current practices and future directions for improving patient safety in laboratory medicine and clinical settings.

Related Concept Videos

Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.9K
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
2.0K
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.8K
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
631